The long-awaited US FDA approval to 'little pink pill' has amassed widespread wrath for many people who consider the very mention of the female Viagra to be sexist as they believe that it is inferior in effectiveness to Viagra.

The female Viagra named flibanserin, will soon be available for sale and is meant to increase the female libido and heighten satisfaction. It would be the first drug of its kind after nearly 20 years when men got theirs in 1990. So, it is claimed that it would lead women across the nation to rejoice!

However, is seems some folks are too happy with this rejoicing, for they claim that sexual dysfunction in women is not very common and it is certainly not worth the risks of the drug as trials have confirmed low blood pressure, dizziness, and sometimes fainting spells in 3% of the subjects.

Moreover, it is argued that Viagra was designed to treat a mechanical issue of lack of blood flow to the penis as opposed to flibanserin which is aimed at sexual desire.

This drug has been rejected twice before by the FDA citing safety and effectiveness concerns. An FDA advisory panel has signed off on the drug last week and it believes that the agency will also approve the drug on Aug. 18 when the final decision is due.

Furthermore, another camp asserts that the issue has been politicized and the views of those who don't think the drug is effective or safe have been labeled as sexist.

Nonetheless, when nearly 43% of the female population suffers from sexual dysfunction, the drug would provide the much needed respite.